Gerhard Winter, LMU Munchen, Germany
A wide range of new data on recent work with solid and semisolid lipid based depot formulations will be presented. As an alternative to PLGA based implants, lipid based rods for long term delivery of protein drugs have been studied in detail. The depot systems consist only of bio [....] » Read More
Title : Understanding the Impact of nanoparticle structure on cellular response
Georgina Kate Such, The University of Melbourne, Australia
Nanoparticle delivery systems have potential for biomedical applications due to the ability of the nanoparticles to better target diseased cells or tissue, and therefore optimise the therapeutic payload to a treatment site. Self- assembled polymeric carriers have generated partic [....] » Read More
Title : Overcoming the barriers to effective targeted drug delivery through stem cell-derived nano-ghosts
Marcelle Machluf, Technion – Israel Institute of Technology, Israel
Targeted drug and gene delivery technologies, mostly for oncological applications, have been extensively investigated for more than three decades. With only seven passively-targeted systems and just two actively-targeted antibody-drug conjugates in oncological use, it seems, howe [....] » Read More
Title : Chimeric and multicompartment drug delivery systems: Lessons learned and future perspectives
Natassa Pippa, University of Athens, Greece
The aim of this investigation is to present the novel progress performed in recent years in the field of design and development of new nanocarriers used in pharmaceutical nanotechnology. Special attention is assigned to chimeric and multicompartment drug delivery systems. Chimeri [....] » Read More
Title : Delivery of siRNA in vivo to the liver using redox sensitive and ionizable lipids
Daniel Zucker, NOF Europe GmbH, Germany
A lipid nanoparticle (LNP) composed of a series of disulfide bridge cleavable and pH-reponsive lipid-like materials (COATOSOME SS-E-P4C2) was developed as a platform of a gene delivery system. The LNP showed good stability in the serum. The tertiary amine and disulfide bridge of [....] » Read More
Title : Getting health allies from agriculture enemies: Plant viruses as smart nanoparticles for vaccine/drug delivery
Selene Baschieri, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Italy
Plant virus nanoparticles (pVNPs) might represent an ideal delivery tool in terms of biocompatibility and biodegradability. They have evolved to use plants as their reproductive hosts, and to this aim, have developed infection strategies very different from those adopted by their [....] » Read More
Title : The influence of gut microbiota-mediated bile acid metabolism on the cellular response to therapeutics at the intestinal barrier
Elaine Frances Enright, University College Cork, Israel
Once regarded obscure, the cohabitation of man and microbe has gained increasing recognition as a determinant of the health status of the host. To date, pharmacokinetic research at the host-microbe interface has been primarily directed towards effects on metabolism. Microbial bil [....] » Read More
Title : Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting
Ilya Yakavets, Universite de Lorraine, France
Application of meta-tetra(hydroxyphenyl)chorin (mTHPC), one of the most potent photosensitizer (PS), in the photodynamic therapy (PDT) of solid tumors encounters several complications resulting from its insolubility in aqueous medium. It requires low light doses and concentration [....] » Read More
Title : ?rabinogalactan and Glycyrrhizic acid as promising agents for oral drug delivery
Mikhail V. Khvostov, N.N. Vorozhtsov Institute of Organic Chemistry SB RAS, Russian Federation
Oral drug delivery is the most popular route because of the low expenses and long-term compliance. However, this introduction route has several limitations for drug molecules. Some of them are low water solubility and poor bioavailability. To overcome these limitations “hos [....] » Read More
Title : Polyethylenimine-based nanoparticles decorated with small molecules mimicking RGD peptide for targeted plasmid DNA delivery
Ali Dehshahri, Shiraz University of Medical Sciences, Iran (Islamic Republic of)
Targeted delivery of polymer-based nanoparticles has been considered as an efficient approach to transfer genetic materials into cells. Considering the over expression of integrin αVβ3 receptor on tumor cells and the presence of the binding site for tetraiodothyroaceti [....] » Read More
Title : Next generation of drug delivery system: Stimuli-sensitive combination nanopreparations
Vladimir P. Torchilin, Northeastern University, United States
Tumor therapy, especially in the case of multidrug resistant cancers, could be significantly enhanced by using siRNA down-regulating the production of proteins, which are involved in cancer cell resistance, such as Pgp or survivin. Even better response could be achieved is such s [....] » Read More
Title : Drug screening and targeting against the stem subpopulation of cancer cells
Esmaiel Jabbari, University of South Carolina, United States
A major contributing factor to mortality in cancer patients is relapse after therapy, and developing resistance. Cancer recurrence and resistance is related to the existence of a very small population of initiating stem cells (CSCs) in the tumor tissue with high expression of ATP [....] » Read More
Title : Targeting nanomedicine to the vascular endothelium
Vladimir Muzykantov, University of Pennsylvania the Perelman School of Medicine, United States
Endothelial cells lining the vascular lumen represent an important therapeutic target in many dangerous maladies. Some of them have no effective pharmacotherapy, at least in part due to inadequate drug delivery to intended site of action. Coupling drugs and carriers with specific [....] » Read More
Title : Nanoparticle delivery of mitochondria-associated microRNA regulating inflammation in the central nervous system
Joe E. Springer, University of Kentucky, United States
Traumatic brain injury (TBI) is a leading cause of long-term impairments in higher cognitive function. Ongoing destructive secondary injury events occur minutes to days after the initial insult characterized by a cascade of pervasive biochemical and pathophysiological stressors i [....] » Read More
Title : Signaling peptides for brain diseases: Delivery and action
Eugenia V Gurevich, Vanderbilt University, United States
Arrestins were discovered as the key proteins responsible for the shutoff of the G protein-dependent signaling by G protein-coupled receptors (GPCRs). Later it was discovered that arrestins regulate multiple signaling pathways, including mitogen activated protein (MAP) kinase pat [....] » Read More